GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
Open Access
- 5 November 2024
- journal article
- research article
- Published by Elsevier in Molecular Metabolism
- Vol. 90, 102052
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Environmental Health Sciences (Z01-ES-101585)
This publication has 63 references indexed in Scilit:
- Molecular pathways involved in injury-repair and ADPKD progressionCellular Signalling, 2020
- Pathway identification through transcriptome analysisCellular Signalling, 2020
- Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney diseaseCellular Signalling, 2020
- Metabolic reprogramming and the role of mitochondria in polycystic kidney diseaseCellular Signalling, 2020
- The PI3K/Akt/mTOR pathway in polycystic kidney disease: A complex interaction with polycystins and primary ciliumCellular Signalling, 2020
- Mechanisms of mammalian mitochondrial transcriptionProtein Science, 2019
- Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and preventionBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2015
- 4D MRI of polycystic kidneys from rapamycin‐treated Glis3‐deficient miceNMR in Biomedicine, 2015
- Oxidation of Alpha-Ketoglutarate Is Required for Reductive Carboxylation in Cancer Cells with Mitochondrial DefectsCell Reports, 2014
- A high-throughput respirometric assay for mitochondrial biogenesis and toxicityAnalytical Biochemistry, 2010